The global increase in diabetes mellitus is leading to a parallel increase in the incidence of cardiovascular complications, which remain the leading cause of death in this patient group. In recent years, the discovery of ferroptosis, an iron-dependent and non-apoptotic form of programmed cell death, has provided new insights into the pathophysiology of diabetes-associated heart disease. This review article deepens the understanding of the molecular mechanisms underlying ferroptosis in the cardiovascular system in diabetes and highlights innovative pharmacological and experimental therapeutic approaches that target ferroptosis pathways.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- GLA:D® program for back pain patients
Fewer consultations and reduction in the use of painkillers
- Nutrition for type 2 diabetes
Not such a great tuber
- From symptom to diagnosis
Abdominal pain – external hernias
- Mechanisms, evidence and therapeutic consequences
GLP-1 receptor agonists in cardiology
- MASLD/MASH
Drug therapy options on the rise: spectacular evidence
- New ways of neuroregeneration
CRISPR and artificial intelligence
- Asbestos victims
Federal Council has decided to amend the UVG
- Music as a cure for cancer?